SCHEMBL6033210

SCHEMBL6033210

c1ccc(/N=N/c2ccc(SSc3ccc(/N=N/c4ccccc4)cc3)cc2)cc1

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.63
MAPT P10636 8/20 0.55
HSD17B10 Q99714 2/20 0.55
SMN1; SMN2 Q16637 2/20 0.55
HPGD P15428 2/20 0.55
MGLL Q99685 1/20 0.55
MEN1 O00255 6/20 0.54
KMT2A Q03164 6/20 0.54
RAB9A P51151 4/20 0.54
NPC1 O15118 4/20 0.54
PKM P14618 1/20 0.54
HTT P42858 1/20 0.54
TDP1 Q9NUW8 5/20 0.48
MAPK1 P28482 4/20 0.48
TSHR P16473 2/20 0.48
TRPA1 O75762 1/20 0.48
KDM4E B2RXH2 1/20 0.45
HSP90AA1 P07900 1/20 0.45
POLB P06746 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20547552 1.00 ALDH1A1 (0.63) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD
SCHEMBL2239365 0.83 ALDH1A1 (0.92) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD
SCHEMBL21024214 0.83 ALDH1A1 (0.92) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD
SCHEMBL13277532 0.83 ALDH1A1 (0.92) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD
SCHEMBL90893 0.83 ALDH1A1 (0.92) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD
SCHEMBL9418780 0.83 ALDH1A1 (0.92) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD
SCHEMBL21023910 0.83 ALDH1A1 (0.92) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD
SCHEMBL13277531 0.83 ALDH1A1 (0.92) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD
SCHEMBL1548295 0.80 ALDH1A1 (0.57) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD
SCHEMBL890355 0.80 ALDH1A1 (0.57) ALDH1A1MAPTHSD17B10SMN1; SMN2HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109232303-B Method for promoting cis-trans isomerization of azobenzene derivative by using black phosphorus nanosheets 南京大学 2020-05-19 CN disclosed
US-20060051761-A1 Organic ultrathin film, cumulate thereof and process for producing the same JAPAN SCIENCE AND TECHNOLOGY AGENCY (JP) 2006-03-09 US disclosed
EP-1547697-A1 ORGANIC ULTRATHIN FILM, CUMULATE THEREOF AND PROCESS FOR PRODUCING THE SAME Japan Science and Technology Agency (JP) 2005-06-29 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060051761-A1 Organic ultrathin film, cumulate thereof and process for producing the same DNMT3A, LIG4, DNMT1 ALDH1A1 2608/4885MAPT 1205/4885HSD17B10 2754/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.